
### [NCIT:C3793](http://purl.obolibrary.org/obo/NCIT_C3793)
**Label:** Inverted Papilloma

**Subclasses:** [NCIT:C6192](http://purl.obolibrary.org/obo/NCIT_C6192) (Inverted Urothelial Papilloma), [NCIT:C4118](http://purl.obolibrary.org/obo/NCIT_C4118) (Inverted Transitional Cell Papilloma), [NCIT:C65165](http://purl.obolibrary.org/obo/NCIT_C65165) (Inverted Squamous Cell Papilloma), [NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma), [NCIT:C6174](http://purl.obolibrary.org/obo/NCIT_C6174) (Ureter Inverted Papilloma), [NCIT:C35835](http://purl.obolibrary.org/obo/NCIT_C35835) (Salivary Gland Inverted Ductal Papilloma), [NCIT:C6173](http://purl.obolibrary.org/obo/NCIT_C6173) (Urethral Inverted Papilloma), [NCIT:C6187](http://purl.obolibrary.org/obo/NCIT_C6187) (Renal Pelvis Inverted Papilloma), 

**Class expressions from DL-Learner:**

- [NCIT:C47826](http://purl.obolibrary.org/obo/NCIT_C47826) (Diffuse Lesion) 53.85%
- [NCIT:C41608](http://purl.obolibrary.org/obo/NCIT_C41608) (Endocrine-Stromal Cell) 53.85%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 53.85%
- Thing 52.89%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38646](http://purl.obolibrary.org/obo/NCIT_C38646) (Fried-Egg Appearance of the Bone Marrow))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38645](http://purl.obolibrary.org/obo/NCIT_C38645) (Tartrate Resistant Acid Phosphatase Positive Cells Present))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38644](http://purl.obolibrary.org/obo/NCIT_C38644) (Bone Pain))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38643](http://purl.obolibrary.org/obo/NCIT_C38643) (Extensive Bone Marrow and Blood Involvement))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38642](http://purl.obolibrary.org/obo/NCIT_C38642) (Lymphoblasts 25 Percent or Less of Bone Marrow Nucleated Cells))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38635](http://purl.obolibrary.org/obo/NCIT_C38635) (inv(22q12)))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38536](http://purl.obolibrary.org/obo/NCIT_C38536) (CREB1 Gene))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38467](http://purl.obolibrary.org/obo/NCIT_C38467) (Interfollicular Area of the Lymph Node))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38459](http://purl.obolibrary.org/obo/NCIT_C38459) (API2-MLT Fusion Protein Expression))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38457](http://purl.obolibrary.org/obo/NCIT_C38457) (Clonal BCL3 Gene Rearrangement))) 39.20%


